These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12947084)

  • 41. Endothelial PAS domain protein 1 gene promotes angiogenesis through the transactivation of both vascular endothelial growth factor and its receptor, Flt-1.
    Takeda N; Maemura K; Imai Y; Harada T; Kawanami D; Nojiri T; Manabe I; Nagai R
    Circ Res; 2004 Jul; 95(2):146-53. PubMed ID: 15192019
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design and synthesis of dihydroindazolo[5,4-a]pyrrolo[3,4-c]carbazole oximes as potent dual inhibitors of TIE-2 and VEGF-R2 receptor tyrosine kinases.
    Dandu R; Zulli AL; Bacon ER; Underiner T; Robinson C; Chang H; Miknyoczki S; Grobelny J; Ruggeri BA; Yang S; Albom MS; Angeles TS; Aimone LD; Hudkins RL
    Bioorg Med Chem Lett; 2008 Mar; 18(6):1916-21. PubMed ID: 18308565
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional knock down of VCAM1 in mice mediated by endoplasmatic reticulum retained intrabodies.
    Marschall AL; Single FN; Schlarmann K; Bosio A; Strebe N; van den Heuvel J; Frenzel A; Dübel S
    MAbs; 2014; 6(6):1394-401. PubMed ID: 25484057
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of the ligand-binding domain of human vascular-endothelial-growth-factor receptor Flt-1.
    Ma L; Wang X; Zhang Z; Zhou X; Chen A; Yao L
    Biotechnol Appl Biochem; 2001 Dec; 34(3):199-204. PubMed ID: 11730488
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types.
    Stoica GE; Kuo A; Powers C; Bowden ET; Sale EB; Riegel AT; Wellstein A
    J Biol Chem; 2002 Sep; 277(39):35990-8. PubMed ID: 12122009
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of endothelial cell angiogenesis receptors in human cerebrovascular malformations.
    Uranishi R; Baev NI; Ng PY; Kim JH; Awad IA
    Neurosurgery; 2001 Feb; 48(2):359-67; discussion 367-8. PubMed ID: 11220380
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of the extracellular domain in vascular endothelial growth factor receptor-1 (Flt-1 tyrosine kinase).
    Tanaka K; Yamaguchi S; Sawano A; Shibuya M
    Jpn J Cancer Res; 1997 Sep; 88(9):867-76. PubMed ID: 9369935
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of adrenomedullin on endothelial cells in the multistep process of angiogenesis: involvement of CRLR/RAMP2 and CRLR/RAMP3 receptors.
    Fernandez-Sauze S; Delfino C; Mabrouk K; Dussert C; Chinot O; Martin PM; Grisoli F; Ouafik L; Boudouresque F
    Int J Cancer; 2004 Mar; 108(6):797-804. PubMed ID: 14712479
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Direct phage to intrabody screening (DPIS): demonstration by isolation of cytosolic intrabodies against the TES1 site of Epstein Barr virus latent membrane protein 1 (LMP1) that block NF-kappaB transactivation.
    Gennari F; Mehta S; Wang Y; St Clair Tallarico A; Palu G; Marasco WA
    J Mol Biol; 2004 Jan; 335(1):193-207. PubMed ID: 14659750
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapeutic effects of viral vector-mediated antiangiogenic gene transfer in malignant ascites.
    Hampl M; Tanaka T; Albert PS; Lee J; Ferrari N; Fine HA
    Hum Gene Ther; 2001 Sep; 12(14):1713-29. PubMed ID: 11560766
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An antagonistic vascular endothelial growth factor (VEGF) variant inhibits VEGF-stimulated receptor autophosphorylation and proliferation of human endothelial cells.
    Siemeister G; Schirner M; Reusch P; Barleon B; Marmé D; Martiny-Baron G
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4625-9. PubMed ID: 9539788
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
    Lu D; Jimenez X; Zhang H; Wu Y; Bohlen P; Witte L; Zhu Z
    Cancer Res; 2001 Oct; 61(19):7002-8. PubMed ID: 11585724
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and biological profile of the pan-vascular endothelial growth factor receptor/tyrosine kinase with immunoglobulin and epidermal growth factor-like homology domains 2 (VEGF-R/TIE-2) inhibitor 11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo[5,4-a]pyrrolo[3,4-c]carbazol-4-one (CEP-11981): a novel oncology therapeutic agent.
    Hudkins RL; Becknell NC; Zulli AL; Underiner TL; Angeles TS; Aimone LD; Albom MS; Chang H; Miknyoczki SJ; Hunter K; Jones-Bolin S; Zhao H; Bacon ER; Mallamo JP; Ator MA; Ruggeri BA
    J Med Chem; 2012 Jan; 55(2):903-13. PubMed ID: 22148921
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intrabodies against the Polysialyltransferases ST8SiaII and ST8SiaIV inhibit Polysialylation of NCAM in rhabdomyosarcoma tumor cells.
    Somplatzki S; Mühlenhoff M; Kröger A; Gerardy-Schahn R; Böldicke T
    BMC Biotechnol; 2017 May; 17(1):42. PubMed ID: 28499450
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acquired antagonistic activity of a bispecific diabody directed against two different epitopes on vascular endothelial growth factor receptor 2.
    Lu D; Kotanides H; Jimenez X; Zhou Q; Persaud K; Bohlen P; Witte L; Zhu Z
    J Immunol Methods; 1999 Nov; 230(1-2):159-71. PubMed ID: 10594363
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tumour-endothelium interactions in co-culture: coordinated changes of gene expression profiles and phenotypic properties of endothelial cells.
    Khodarev NN; Yu J; Labay E; Darga T; Brown CK; Mauceri HJ; Yassari R; Gupta N; Weichselbaum RR
    J Cell Sci; 2003 Mar; 116(Pt 6):1013-22. PubMed ID: 12584245
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.
    Béliveau R; Gingras D; Kruger EA; Lamy S; Sirois P; Simard B; Sirois MG; Tranqui L; Baffert F; Beaulieu E; Dimitriadou V; Pépin MC; Courjal F; Ricard I; Poyet P; Falardeau P; Figg WD; Dupont E
    Clin Cancer Res; 2002 Apr; 8(4):1242-50. PubMed ID: 11948139
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Potential roles of metalloprotease mediated ectodomain cleavage in signaling by the endothelial receptor tyrosine kinase Tie-1.
    McCarthy MJ; Burrows R; Bell SC; Christie G; Bell PR; Brindle NP
    Lab Invest; 1999 Jul; 79(7):889-95. PubMed ID: 10418829
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhanced antiangiogenic therapy of squamous cell carcinoma by combined endostatin and epidermal growth factor receptor-antisense therapy.
    Li M; Ye C; Feng C; Riedel F; Liu X; Zeng Q; Grandis JR
    Clin Cancer Res; 2002 Nov; 8(11):3570-8. PubMed ID: 12429648
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proliferation of endothelial and tumor epithelial cells by progestin-induced vascular endothelial growth factor from human breast cancer cells: paracrine and autocrine effects.
    Liang Y; Hyder SM
    Endocrinology; 2005 Aug; 146(8):3632-41. PubMed ID: 15845615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.